Page 21 - OR-1-2

phenotypes in patient neuronal cultures and brain organoids 81. Zheng X, Han D, Liu W, et al. Human iPSC-derived midbrain
improved by 2-hydroxypropyl-β-cyclodextrin treatment. organoids functionally integrate into striatum circuits and
Mov Disord. 2022;37(1):80-94. restore motor function in a mouse model of Parkinson’s
disease. Theranostics. 2023;13(8):2673-2692.
doi: 10.1002/mds.28810
doi: 10.7150/thno.80271
71. Sai M, Hank EC, Tai HM, et al. Development of nurr1
agonists from amodiaquine by scaffold hopping and 82. Fu CL, Jiang X, Dong BC, Li D, She XY, Yao J. Protocol
fragment growing. Commun Chem. 2024;7(1):149. for transplantation of cells derived from human midbrain
organoids into a Parkinson’s disease mouse model to restore
doi: 10.1038/s42004-024-01224-0
motor function. STAR Protoc. 2024;5(3):103251.
72. Jin Y, Li F, Li Z, et al. Modeling lewy body disease with SNCA
triplication iPSC-derived cortical organoids and identifying doi: 10.1016/j.xpro.2024.103251
therapeutic drugs. Sci Adv. 2024;10(37):eadk3700. 83. Fu CL, Dong BC, Jiang X, Li D, Yao J. A cell therapy
approach based on iPSC-derived midbrain organoids for the
doi: 10.1126/sciadv.adk3700
restoration of motor function in a Parkinson’s disease mouse
73. Quadrato G, Nguyen T, Macosko EZ, et al. Cell diversity and model. Heliyon. 2024;10(2):e24234.
network dynamics in photosensitive human brain organoids.
Nature. 2017;545(7652):48-53. doi: 10.1016/j.heliyon.2024.e24234
84. Daadi MM, Grueter BA, Malenka RC, Redmond DE Jr.,
doi: 10.1038/nature22047
Steinberg GK. Dopaminergic neurons from midbrain-
74. Pollen AA, Bhaduri A, Andrews MG, et al. Establishing specified human embryonic stem cell-derived neural stem
cerebral organoids as models of human-specific brain cells engrafted in a monkey model of Parkinson’s disease.
evolution. Cell. 2019;176(4):743-756 e17. PLoS One. 2012;7(7):e41120.
doi: 10.1016/j.cell.2019.01.017 doi: 10.1371/journal.pone.0041120
75. Brancati G, Treutlein B, Camp JG. Resolving 85. Nam YR, Kang M, Kim M, et al. Preparation of human
neurodevelopmental and vision disorders using organoid astrocytes with potent therapeutic functions from human
single-cell multi-omics. Neuron. 2020;107(6):1000-1013. pluripotent stem cells using ventral midbrain patterning.
doi: 10.1016/j.neuron.2020.09.001 J Adv Res. 2024;69:181-196.
76. Phan N, Hong JJ, Tofig B, et al. A simple high-throughput doi: 10.1016/j.jare.2024.03.012
approach identifies actionable drug sensitivities in patient- 86. Andrews MG, Kriegstein AR. Challenges of organoid
derived tumor organoids. Commun Biol. 2019;2:78. research. Annu Rev Neurosci. 2022;45:23-39.
doi: 10.1038/s42003-019-0305-x doi: 10.1146/annurev-neuro-111020-090812
77. Zhou C, Wu Y, Wang Z, et al. Standardization of organoid 87. Bose S, Clevers H, Shen X. Promises and challenges of
culture in cancer research. Cancer Med. 2023;12(13): organoid-guided precision medicine. Med. 2021;2(9):
14375-14386. 1011-1026.
doi: 10.1002/cam4.5943 doi: 10.1016/j.medj.2021.08.005
78. Revah O, Gore F, Kelley KW, et al. Maturation and circuit 88. Ahammed B, Kalangi SK. A decade of organoid research:
integration of transplanted human cortical organoids. Progress and challenges in the field of organoid technology.
Nature. 2022;610(7931):319-326. ACS Omega. 2024;9(28):30087-30096.
doi: 10.1038/s41586-022-05277-w doi: 10.1021/acsomega.4c03683
79. Westerling-Bui AD, Fast EM, Soare TW, et al. Transplanted 89. Hong SJ, Bock M, Zhang S, An SB, Han I. Therapeutic
organoids empower human preclinical assessment of drug transplantation of human central nervous system organoids
candidate for the clinic. Sci Adv. 2022;8(27):eabj5633. for neural reconstruction. Int J Mol Sci. 2024;25(15):8540.
doi: 10.1126/sciadv.abj5633 doi: 10.3390/ijms25158540
80. Jgamadze D, Harary PM, Castellanos M, et al. Protocol 90. Bellotti C, Samudyata S, Thams S, Sellgren CM, Rostami E.
for human brain organoid transplantation into a rat Organoids and chimeras: The hopeful fusion transforming
visual cortex to model neural repair. STAR Protoc. 2023; traumatic brain injury research. Acta Neuropathol Commun.
4(3):102470. 2024;12(1):141.
doi: 10.1016/j.xpro.2023.102470 doi: 10.1186/s40478-024-01845-5

Volume 1 Issue 2 (2025) 12 doi: 10.36922/OR025040006